Prostate tumors expressed SLCO1B3 much more frequently than normal prostate tissues (62% vs. 0%, n = 21 and n = 5 respectively; P = 0.04) and more frequently with increasing Gleason score (P = 0.03). Here, SLCO1B3 is linked to prostate neoplasm.